| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3895780
Max Phase: Preclinical
Molecular Formula: C17H14N2O3
Molecular Weight: 294.31
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=[N+]([O-])c1cccc(C2NCCc3c2oc2ccccc32)c1
Standard InChI: InChI=1S/C17H14N2O3/c20-19(21)12-5-3-4-11(10-12)16-17-14(8-9-18-16)13-6-1-2-7-15(13)22-17/h1-7,10,16,18H,8-9H2
Standard InChI Key: WYKURZVILQMQNZ-UHFFFAOYSA-N
Associated Targets(non-human)
Sodium/iodide cotransporter 83 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 294.31 | Molecular Weight (Monoisotopic): 294.1004 | AlogP: 3.58 | #Rotatable Bonds: 2 |
| Polar Surface Area: 68.31 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.46 | CX LogP: 3.37 | CX LogD: 3.04 |
| Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.58 | Np Likeness Score: -0.28 |
References
| 1. (2014) Heterocyclic compounds as inhibitors of the sodium iodide symporter, |
Source
Source(1):